吞噬作用
免疫学
吞噬小体
肺结核
中性粒细胞胞外陷阱
调理素
ESAT-6号
髓过氧化物酶
粒细胞
亚临床感染
疾病
生物
医学
结核分枝杆菌
炎症
病理
病毒学
吞噬体
作者
O Rojas-Espinosa,Miguel Angel Rivero-Silva,Alejandro Hernández-Solís,Patricia Arce‐Paredes,Alma Y. Arce‐Mendoza,Sergio Islas-Trujillo
标识
DOI:10.4103/ijmy.ijmy_134_21
摘要
Background: It has been reported that sera from patients with active pulmonary tuberculosis (APT) induced nuclear changes in normal neutrophils that included pyknosis, swelling, apoptosis, and production of extracellular traps (NETs). Similar changes were observed with some sera from their household contacts but not with sera from healthy, unrelated individuals. It was suggested that those sera from household contacts that induced neutrophil nuclear changes might correspond to people with subclinical tuberculosis. Thus, our experimental approach might serve to identify individuals with early, ongoing disease. Methods: Nuclear changes in neutrophils were fully evident by 3 h of contact and beyond. Circulating mycobacterial antigens were the most likely candidates for this effect. We wanted to know whether the nuclear changes induced on neutrophils by the sera of APT patients would negatively affect the phagocytic/microbicidal ability of neutrophils exposed to APT sera for short periods. Results: We now provide evidence that short-term contact (30 min) with sera from patients with pulmonary tuberculosis increases several phagocytic parameters of normal neutrophils, including endocytosis, myeloperoxidase levels, production of free reactive oxygen species, phagolysosome fusion, and microbicidal activity on Staphylococcus aureus , with these effects not being observed with sera from healthy donors. We also give evidence that suggests that ESAT-6 and CFP-10 are involved in the phenomenon. Conclusion: We conclude that activation is a stage that precedes lethal nuclear changes in neutrophils and suggests that autologous neutrophils must circulate in an altered state in the APT patients, thus contributing to the pathology of the disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI